Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Lister-James is active.

Publication


Featured researches published by John Lister-James.


The Journal of Clinical Pharmacology | 1993

External Imaging of Atherosclerosis in Rabbits Using an 123I‐Labeled Synthetic Peptide Fragment

Ruth Hardoff; Frank Braegelmann; Pat Zanzonico; Edmund M. Herrold; Robert S. Lees; Ann M. Lees; Richard T. Dean; John Lister-James; Jeffrey S. Borer

The oligopeptide fragment of apolipoprotein B, SP‐4, has demonstrated pronounced uptake in the healing edges of balloon‐injured rabbit aortic endothelium. To assess 123I‐labeled SP‐4 for identification of atherosclerotic plaques by gamma camera imaging, 14 Watanabe heritable hyperlipidemic (WHHL) and 5 normal rabbits were imaged 5 minutes and 12 and 24 hours after intravenous injection of123I‐SP‐4. In addition, two WHHL and two normal rabbits were injected with 125I‐SP‐4 for autoradiography. Twelve of the 14 WHHL, but none of the normal, rabbits had visually apparent focal radioiodine accumulation in the region of the aorta. Focus‐to‐lung and focus‐to‐heart count ratios were 2.4 ± 1.3 and 1.0 ± 0.4, respectively. Five of the visually positive WHHL rabbits were reimaged 4 and 8 weeks later with 123I‐NaI and 123I‐SP‐2 (an apo E peptide), respectively, as negative controls. Perceptible, but faint, aortic localization of 123I‐NaI and of 123I‐SP‐2 was seen in only one animal each. The distributions of atherosclerotic lesions on photographs of the opened WHHL aortas and of film blackening on 125I‐SP‐4 autoradiograms were identical. In contrast, the two normal rabbit aortas did not exhibit plaques on photographs or film blackening on autoradiograms. Thus, in an animal model closely simulating human atherosclerotic disease, SP‐4 localizes specifically in aortic atherosclerotic lesions.


The Journal of Nuclear Medicine | 1996

Preclinical Evaluation of Technetium-99m-Labeled Somatostatin Receptor-Binding Peptides

Shankar Vallabhajosula; Brian R. Moyer; John Lister-James; Bill McBride; Helena Lipszyc; Hiram Lee; Diago Bastidas; R. T. Dean


JAMA Internal Medicine | 2003

Imaging Characteristics of a Novel Technetium Tc 99m–Labeled Platelet Glycoprotein IIb/IIIa Receptor Antagonist in Patients With Acute Deep Vein Thrombosis or a History of Deep Vein Thrombosis

Shannon M. Bates; John Lister-James; Jim A. Julian; Raymond Taillefer; Brian R. Moyer; Jeffrey S. Ginsberg


Bioconjugate Chemistry | 1990

Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugate.

Robert W. Weber; Raymond H. Boutin; Mark A. Nedelman; John Lister-James; Richard T. Dean


The Journal of Nuclear Medicine | 1996

Technetium-99m-White Blood Cell-Specific Imaging Agent Developed from Platelet Factor 4 to Detect Infection

Brian R. Moyer; Shankar Vallabhajosula; John Lister-James; Larry R. Bush; John E. Cyr; Debra A. Snow; Diego Bastidas; Helena Lipszyc; R. T. Dean


The Journal of Nuclear Medicine | 1997

Pre-Clinical Evaluation of Technetium-99m Platelet Receptor-Binding Peptide

John Lister-James; Shankar Vallabhajosula; Brian R. Moyer; Daniel A. Pearson; Bill McBride; Mark A. De Rosch; Larry R. Bush; Josef Machac; R. T. Dean


Nuclear Medicine Communications | 2000

Characterization and tumor retention of Tc-99m P1666, a vasoactive intestinal peptide analog, in two animal models and patients with adenocarcinoma

C. A. Nelson; I. Virgolini; Daniel A. Pearson; D. M. Wilson; W. B. Jones; J. E. Cyr; John Lister-James; R. T. Dean


Nuclear Medicine Communications | 2000

Radiolabeled P1410, a calcitonin analog, targets human breast cancer xenografts in nude mice

C. A. Nelson; Brian R. Moyer; Daniel A. Pearson; R. Manchanda; D. M. Wilson; J. V. Rutkowski; John Lister-James; R. T. Dean


Nuclear Medicine Communications | 2000

Lung cancer - from radiodiagnosis to radiotherapy with novel somatostatin-receptor-binding peptides

R. Manchanda; M. T. Azure; Daniel A. Pearson; D. M. Wilson; Brian R. Moyer; C. A. Nelson; J. E. Cyr; M. A. De Rosch; W. B. Jones; Y. Baran; John Lister-James; R. T. Dean


Nuclear Medicine Communications | 2000

Metabolism of NeoTectTM and [3H-Tyr]depreotide peptide in Sprague-Dawley rats

Brian R. Moyer; R. Manchanda; Daniel A. Pearson; J. E. Cyr; E. J. Little; John Lister-James; R. T. Dean

Collaboration


Dive into the John Lister-James's collaboration.

Top Co-Authors

Avatar

R. T. Dean

National Heart Foundation of Australia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ann M. Lees

National Heart Foundation of Australia

View shared research outputs
Top Co-Authors

Avatar

Bill McBride

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jeffrey S. Borer

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge